HomeADCT • NYSE
add
ADC Therapeutics SA
Previous close
$4.35
Day range
$4.12 - $4.56
Year range
$1.05 - $4.98
Market cap
524.69M USD
Avg Volume
875.98K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 23.06M | 36.36% |
Operating expense | 21.44M | 2.72% |
Net income | -6.41M | 79.14% |
Net profit margin | -27.80 | 84.70% |
Earnings per share | — | — |
EBITDA | -15.98M | 47.73% |
Effective tax rate | 5.93% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 261.34M | 4.17% |
Total assets | 323.15M | 0.36% |
Total liabilities | 508.98M | -2.98% |
Total equity | -185.83M | — |
Shares outstanding | 127.04M | — |
Price to book | -2.94 | — |
Return on assets | -13.04% | — |
Return on capital | -16.90% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -6.41M | 79.14% |
Cash from operations | -31.12M | -42.43% |
Cash from investing | 659.00K | 832.22% |
Cash from financing | 57.09M | 5,197.23% |
Net change in cash | 26.60M | 213.65% |
Free cash flow | -2.90M | -119.84% |
About
Founded
2011
Website
Employees
191
